Minerva Neurosciences, Inc (NERV) earnings
NERV earnings moved a median of -1.67% by the close. Quarterly and annual NERV reports and results, each read against the price at its own news timestamp. Back to the NERV overview →
17 measured NERV earnings events.
Where these NERV earnings landedvs 17 measured NERV earnings reactions
| Middle 50% of NERV earnings reactions | -2.73% to +1.54% |
|---|---|
| Median reaction (to close) | -1.67% |
| Measured reactions | 17 |
Point-in-time · zero look-ahead
Half of the 17 NERV earnings events with a measured close landed between -2.73% and +1.54%; 35% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Minerva Neurosciences, For: Jun 30 | SEC filing · Form 10-Q | +2.39% | -2.73% | |
| Form 10-Q Minerva Neurosciences, For: Mar 31 | SEC filing · Form 10-Q | -1.09% | -2.19% | |
| Form 10-K Minerva Neurosciences, For: Dec 31 | SEC filing · Form 10-K | +0.65% | -4.58% | |
| Form 10-Q Minerva Neurosciences, For: Sep 30 | SEC filing · Form 10-Q | +0.86% | +9.14% | |
| Form 10-Q Minerva Neurosciences, For: Jun 30 | SEC filing · Form 10-Q | +2.02% | +20.97% | |
| Form 10-Q Minerva Neurosciences, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -1.81% | |
| Form 10-K/A Minerva Neurosciences, For: Dec 31 | SEC filing · Form 10-K | -0.59% | +1.47% | |
| Form 10-K/A Minerva Neurosciences, For: Dec 31 | SEC filing · Form 10-K | +0.56% | -2.84% | |
| Form 10-K Minerva Neurosciences, For: Dec 31 | SEC filing · Form 10-K | -2.78% | -0.56% | |
| Form 10-Q Minerva Neurosciences, For: Sep 30 | SEC filing · Form 10-Q | +2.55% | -1.67% | |
| Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates | Press release | +2.55% | -1.67% | |
| Form 10-Q Minerva Neurosciences, For: Jun 30 | SEC filing · Form 10-Q | +0.00% | +5.38% | |
| Form 10-Q Minerva Neurosciences, For: Mar 31 | SEC filing · Form 10-Q | +0.00% | +3.00% | |
| Form 10-K/A Minerva Neurosciences, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -2.32% | |
| Form 10-K/A Minerva Neurosciences, For: Dec 31 | SEC filing · Form 10-K | -0.14% | -5.03% | |
| Form 10-K Minerva Neurosciences, For: Dec 31 | SEC filing · Form 10-K | +5.62% | -18.54% | |
| Form 10-Q Minerva Neurosciences, For: Sep 30 | SEC filing · Form 10-Q | — | +1.54% |
Keep exploring
More NERV: analyst actions → · SEC filings → · NERV overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MediWound Ltd. - Ordinary Shares (MDWD) | 166 | +0.11% | 53% |
| XBiotech Inc. (XBIT) | 165 | 0.00% | 45% |
| NIGHTSTAR THERAPEUTICS PLC AMERICAN DEPOSITARY SHA (NITE) | 164 | -0.04% | 28% |
| NanoViricides, Inc. (NNVC) | 164 | +0.01% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.